The FDA has delayed granting full approval of Novavax's COVID-19 vaccine despite it being on track to be cleared until ...
The US drug regulator has missed a deadline for granting full approval to Novavax's COVID-19 vaccine, the company said ...
BioNTech (NASDAQ:BNTX – Get Free Report) had its target price dropped by analysts at HC Wainwright from $150.00 to $145.00 in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results